Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF1R | P08069 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6845096 | 0.92 | P2RX3 (0.32) | IGF1RKCNH2CHEK2 | |
| SCHEMBL954510 | 0.90 | IGF1R (0.35) | IGF1RKCNH2 | |
| SCHEMBL954657 | 0.86 | IKBKB (0.37) | IGF1RKCNH2CHEK2 | |
| SCHEMBL6842774 | 0.82 | MEN1 (0.31) | KCNH2 | |
| SCHEMBL6842770 | 0.82 | LMNA (0.35) | IGF1RKCNH2 | |
| SCHEMBL16937985 | 0.76 | IGF1R (0.34) | IGF1RKCNH2 | |
| SCHEMBL952263 | 0.74 | KHK (0.36) | IGF1RKCNH2 | |
| SCHEMBL6845067 | 0.74 | MEN1 (0.32) | — | |
| SCHEMBL13256713 | 0.73 | MAP4K1 (0.32) | — | |
| SCHEMBL6845055 | 0.73 | CNR1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9090601-B2 | Thiazole derivatives | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2015-07-28 | — | — | US | disclosed |
| US-20110003807-A1 | Thiazole derivatives | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2011-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110003807-A1 | Thiazole derivatives | MTOR, RICTOR, AKT2 | IGF1R 57/4885KCNH2 4419/4885CHEK2 873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.